Ombitasvir/Paritaprevir/Ritonavir dasabuvir
Showing 26 - 50 of 823
ABT-450/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic
Completed
- Chronic Hepatitis C
- (no location specified)
May 1, 2019
Hepatitis C, Chronic Trial in Sydney ("3D" regimen, "3D" regimen with ribavirin)
Completed
- Hepatitis C, Chronic
- "3D" regimen
- "3D" regimen with ribavirin
-
Sydney, New South Wales, AustraliaThe Kirby Institute, University of New South Wales Australia
Jun 11, 2019
Hepatitis C Virus Infection Trial (OBV/PTV/r) ± ribavirin (RBV))
Completed
- Hepatitis C Virus Infection
- OBV/PTV/r) ± ribavirin (RBV)
- (no location specified)
May 9, 2020
Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)
Completed
- Hepatitis C Virus
- (no location specified)
Jul 28, 2021
Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic
Completed
- Chronic Hepatitis C
- (no location specified)
Mar 26, 2019
Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic
Completed
- Chronic Hepatitis C
- (no location specified)
Oct 22, 2018
Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)
Chronic Hepatitis C Virus Infection Trial in Beni-Suef (SOF plus (OBV/PTV/r) plus RBV)
Completed
- Chronic Hepatitis C Virus Infection
- SOF plus (OBV/PTV/r) plus RBV
-
Beni-Suef, EgyptBeni-Suef University
May 13, 2020
Viekira/Exviera for Korean Hepatitis C Patients According to
Completed
- Hepatitis C Virus (HCV)
-
Busan, Busan Gwang Yeogsi, Korea, Republic of
- +58 more
Oct 6, 2020
Resistance to AbbVie's 2 Direct-acting Antiviral Agent Therapy
Completed
- Hepatitis C Virus
-
Nagoya-shi, Aichi, Japan
- +52 more
Dec 6, 2021
End-stage Renal Disease, HCV Coinfection Trial in Assiut (Ombitasvir / Paritaprevir / Ritonavir /Ribavirin Oral Tablet)
Completed
- End-stage Renal Disease
- HCV Coinfection
- Ombitasvir / Paritaprevir / Ritonavir /Ribavirin Oral Tablet
-
Assiut, EgyptAssiut University Hopsital
Jan 8, 2020
Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks
Completed
- Hepatitis C Infection
- ombitasvir/paritaprevir/ritonavir 8 weeks
- dasabuvir 8 weeks
-
Barcelona, SpainCarrion, Jose Antonio, PhD
May 18, 2018
Chronic Hepatitis C Trial (paritaprevir/ritonavir/ombitasvir + dasabuvir +/- ribavirin)
Completed
- Chronic Hepatitis C
- paritaprevir/ritonavir/ombitasvir + dasabuvir +/- ribavirin
- (no location specified)
Oct 17, 2018
Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in
Completed
- Chronic Hepatitis C
-
Marseille CEDEX 08, Bouches-du-Rhone, France
- +69 more
Mar 13, 2019